Abbvie (ABBV) Price Increases Imply Some Upside to Street Models - Piper Sandler
Tweet Send to a Friend
Piper Sandler analyst Christopher Raymond reiterated an Overweight rating and $160.00 price target on Abbvie (NYSE: ABBV) citing a Wolters ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
